Correlation of PIK3CA mutation with pathological complete response in primary HER2-positive breast cancer: Combined analysis of 967 patients from three prospective clinical trials Meeting Abstract


Authors: Loibl, S.; Majewski, I.; Guarneri, V.; Nekljudova, V.; Holmes, E. M.; Bria, E.; Denkert, C.; Eidtmann, H.; Sotiriou, C.; Loi, S.; André, F.; Untch, M.; Conte, P. F.; Piccart-Gebhart, M. J.; Von Minckwitz, G.; Baselga, J.
Abstract Title: Correlation of PIK3CA mutation with pathological complete response in primary HER2-positive breast cancer: Combined analysis of 967 patients from three prospective clinical trials
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901118
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.511
Notes: Meeting Abstract: 511 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga